Table 3.
Predictors of AAs recurrence after the initial CA.
| Univariable analysis | Multivariable analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Age, years old | 0.71 | 0.97–1.02 | 0.71 | |||
| Minimum continuous AF duration, month | 1.01 | 1.00–1.03 | 0.033 | 1.01 | 1.00–1.03 | 0.015 |
| Unknown time of AF onset | 0.96 | 0.55–1.66 | 0.87 | |||
| BMI, kg/m2 | 0.99 | 0.93–1.06 | 0.82 | |||
| Hypertension | 0.96 | 0.60–1.56 | 0.88 | |||
| CHA2DS2-VASc score | 0.27 | 0.61–1.15 | 0.26 | |||
| LAD, mm | 1.01 | 0.96–1.06 | 0.82 | |||
| LVEF, % | 1.00 | 0.97–1.03 | 0.95 | |||
| BNP, pg/ml | 1.00 | 0.99–1.00 | 0.95 | |||
| Ccr, ml/min | 0.99 | 0.98–1.00 | 0.16 | |||
| Start in AF rhythm | 2.24 | 1.03–4.90 | 0.044 | 1.78 | 0.80–3.94 | 0.16 |
| EGM-guided ablation | 2.62 | 1.59–4.34 | 0.0002 | 2.45 | 1.47–4.09 | 0.0007 |
| Non-PV foci including SVC | 1.46 | 0.73–2.95 | 0.29 | |||
Significant values are in bold.
AF atrial fibrillation, BMI body mass index, BNP brain natriuretic peptide, Ccr creatinine crealance, LAD left atrial diameter, LVEF left ventricular ejection fraction, OR odds ratio, SVC superior vena cava.